The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic valuation realization and scientific discovery.

資産クラス

Equity

運用会社

Horizon Kinetics

設定国

US

設定日

2023年1月26日

保有銘柄数

32

ISIN

US53656G5633